Stocks on the move: M, TRNC, COTY >>> READ MORE

Top 10 Dow Dividend Stocks for November

Looking for reliable blue-chip income? You've found it.

      View All  

#8: Pfizer (PFE)

pfizer-stock-pfe-dividend-stocksDividend Yield: 3%
YTD Performance: +29%

When big pharmaceutical companies are confronted with expiring patents on their blockbuster drugs, they have to do something to keep shareholders happy.

Cost-cutting is one way Pfizer (PFE) is making things right, but most investors probably feel better knowing it still throws off a 3% yield — and still has managed to outpace the S&P 500 this year by a couple percentage points.

Not bad for a dividend stock that increasingly looks like a bond in drag.

The long-term growth forecast stands at less than 3% a year for the next five years or so. Ordinarily, that would make the forward P/E of 14 look like a bit of a stretch, but between the dividend and $10 billion share repurchase program, new money looks to get its money’s worth.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC